[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
December 12, 2001

Cardiovascular Events and COX-2 Inhibitors

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(22):2808-2813. doi:10.1001/jama.286.22.2808

To the Editor: I am troubled by the letter I received by overnight delivery from Louis Sherwood, MD, Senior Vice President for US Medical and Scientific Affairs at Merck. He sent a "Dear Healthcare Provider" letter in response to the article by Dr Mukherjee and colleagues.1 Sherwood directly disparages the article as "not new" and offers to supplant its findings with Merck's "confidence" in their product. A full text copy of the package insert was also included.

First Page Preview View Large
First page PDF preview
First page PDF preview
×